DelMar Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DMPI and buy or sell other stocks, options, and ETFs commission-free!About DMPI
Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001.
CEORobert E. Hoffman, CPA
CEORobert E. Hoffman, CPA
Employees17
Employees17
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2009
Founded2009
Employees17
Employees17
DMPI Key Statistics
Market cap108.08M
Market cap108.08M
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume4.83M
Average volume4.83M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.98
52 Week high$5.98
52 Week low$0.081
52 Week low$0.081